Benitec Biopharma Inc. (BNTC)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

8.87 on 9 Oct 2026

7 buys0 sales at will0 planned sales

Fiscal year 2024, ended 30 Jun 2024, as filed

Revenue

$0.00

Net income

$21.75M

Free cash flow

$19.58M

Return on equity

-46.0%

Return on capital

-37.6%

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
29 Dec 2025	MONTANOVA CAPITAL, LLC Director	Bought	$1.04M	0.8%
26 Dec 2025	MONTANOVA CAPITAL, LLC Director	Bought	$220.55K	0.2%
23 Dec 2025	MONTANOVA CAPITAL, LLC Director	Bought	$642.50K	0.5%
22 Dec 2025	MONTANOVA CAPITAL, LLC Director	Bought	$236.07K	0.2%
19 Dec 2025	MONTANOVA CAPITAL, LLC Director	Bought	$188.09K	0.2%
18 Dec 2025	MONTANOVA CAPITAL, LLC Director	Bought	$114.82K	0.1%

32out of 100

Profitability 6

Financial strength 67

Growth 0

Insiders 65

Strongest on financial strength (67), weakest on growth (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$22.44M

7 buys, 1 buyer

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan